Shares of Hologic Inc. HOLX shed 2.35% to $56.50 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and Dow ...

BofA lowered the firm’s price target on Hologic (HOLX) to $70 from $86 and keeps a Neutral rating on the shares. Sentiment for Life Sciences ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Hologic (HOLX) ended the recent trading session at $58.84, demonstrating a +1.71% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily gain of 0.79%.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Hologic Inc. closed 31.68% below its 52-week high of $84.67, which the company reached on August 9th.

Lucky loser Jessika Ponchet is into her first quarterfinal at a Hologic WTA Tour event, after she defeated her fellow Frenchwoman Fiona Ferro 7-6(4), 6-4 on their home soil of the Open Capfinances ...

Hologic, Inc. (NASDAQ:HOLX – Get Free Report) has earned a consensus recommendation of “Hold” from the seventeen analysts that are currently covering the company, Marketbeat.com reports. Eleven ...

CureMetrix expands FDA clearance for cmAngio to include GE Healthcare, increasing access for more women to AI-powered BAC detection in mam ...